Putnam BioRevolution ETF (SYNB)

Assets	$4.12M
NAV	$27.49
Expense Ratio	0.70%
PE Ratio	n/a
Shares Out	150,000
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
1-Year Return	n/a

Volume	n/a
Open	n/a
Previous Close	26.92
Day's Range	26.53 - 27.52
52-Week Low	24.45
52-Week High	27.52
Beta	n/a
Holdings	42
Inception Date	Sep 29, 2022

About SYNB

The Putnam BioRevolution ETF (SYNB) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund actively invests in companies of all sizes around the globe that enable biological innovation. SYNB was launched on Sep 29, 2022 and is managed by Putnam.

• Asset Class: Equity
• Stock Exchange: NYSEARCA
• Ticker Symbol: SYNB
• Issuer Website: Putnam

Top 10 Holdings

50.09% of assets

Name	Symbol	Weight
Danaher Corporation	DHR	7.15%
Eli Lilly and Company	LLY	6.18%
Alphabet, Inc.	GOOGL	5.89%
Bio-Rad Laboratories, Inc.	BIO	5.36%
Thermo Fisher Scientific, Inc.	TMO	4.64%
AstraZeneca plc	AZN	4.33%
Merck & Co., Inc.	MRK	4.33%
Net Cash	n/a	4.28%
Avantor, Inc.	AVTR	4.20%
Corteva, Inc.	CTVA	3.73%